ReviewCurrent opinion in obstetrics & gynecology2020

Targeting human epidermal growth factor receptor 2 (HER2) in gynecologic malignancies.

Britt K Erickson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.